Darrell has broad responsibilities related to international expansion. Darrell also maintains close surveillance of the investment environment and advises clients on asset allocation. Darrell has been a senior equity products specialist of T. Rowe Price Associates and was previously an investment analyst in the Equity Research Group covering medical technology, hospital supply, and specialty pharmaceutical companies. Prior to joining the firm in 1997, he was an analyst at the investment management firm of Sanford C. Bernstein & Co., Inc., in New York. He was previously a director of Pharmaceutical and Medical Device Business Development for American Cyanamid (acquired by American Home Products and now called Wyeth) and a business planning analyst for Eli Lilly & Co. Darrell has an undergraduate degree in Psychobiology with highest honors from UCLA and an M.B.A. in Finance, Marketing, and Statistics from the University of Chicago.